Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 182 participants.
Also called NCT04784013
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 182 participants
- Sponsor
- Registry
-
NCT04784013
-
- Other papers using this trial's data
- Very High-Power Ablation for Contiguous Pulmonary Vein Isolation: Results From the Randomized POWER PLUS Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Belgium, Netherlands, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT04784013. Randomized; no masking; primary purpose treatment. Start 2021-03-24 (actual); primary completion 2021-10-22 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Very High Power Ablation in Patients With Atrial Fibrillation Scheduled for a First Pulmonary Vein Isolation
- Acronym
- POWER-PLUS
- Condition
- Atrial Fibrillation
- Intervention (Procedure)
- Conventional CLOSE-guided pulmonary vein isolation
- Intervention (Procedure)
- High power short duration pulmonary vein isolation
- Lead sponsor
- AZ Sint-Jan AV
Record details
- Record id
cardio:ct-nct04784013- Content hash
e14f6b5b11265ded391eb90f857516c41cbf97e73b416648bdb6dafaea963570